Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
999 studies found for:    "North American Indian childhood cirrhosis" OR "Liver Cirrhosis"
Show Display Options
Rank Status Study
21 Unknown  TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Drug: Fuzhenghuayu Tablet, Huangqi Decoction Granule
22 Completed Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Drug: Ng-monomethyl-L-arginine (drug)
23 Unknown  Umbilical Cord Blood Mononuclear Cells Therapy in Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Biological: Umbilical Cord Blood Mononuclear Cells
24 Completed
Has Results
Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: G-colony stimulating factor;   Other: Infusion of the mobilized monocyte cells
25 Recruiting The Effect of Resistance Training on Muscle Strength and Nutritional Status in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Behavioral: Nutrition and strength training;   Behavioral: Nutrition
26 Completed Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Other: Venous blood
27 Completed Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Other: Autologous bone marrow-derived endothelial progenitor cells
28 Completed Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Dietary Supplement: Branched-chain aminoacids;   Other: High-fiber high protein diet
29 Completed Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: Placebo;   Drug: Rifaximin SSD 40 mg IR tablet;   Drug: Rifaximin SSD 80 mg IR tablet;   Drug: Rifaximin SSD 40 mg SER tablet;   Drug: Rifaximin SSD 80 mg SER tablet;   Drug: Rifaximin SSD 80 mg IR tablet + rifaximin SSD 80 mg SER tablet
30 Completed Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis
Condition: Alcoholic Liver Cirrhosis
Intervention: Biological: Allogeneic Mesenchymal Stem Cells
31 Terminated Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone
Condition: Liver Cirrhosis
Interventions: Drug: Dexamethasone;   Drug: Placebo
32 Terminated Cytokines and the Risk of Infection in Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention:
33 Recruiting Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Device: annual noncontrast MRI;   Device: biannual ultrasonography
34 Enrolling by invitation Long-term Follow-up Study of Livercellgram in Alcoholic Liver Cirrhosis Patients Who Completed Livercellgram Phase 2 Study
Condition: Alcoholic Liver Cirrhosis
Intervention: Biological: Livercellgram
35 Completed REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)
Condition: Alcoholic Liver Cirrhosis
Intervention: Biological: Livercellgram
36 Recruiting Cirrhosis, Effects of TRAnsplantation and Diabetes
Condition: Liver Cirrhosis
Intervention:
37 Recruiting SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy
Condition: Liver Cirrhosis, Alcoholic
Interventions: Behavioral: Supervised exercise;   Other: Usual Care;   Behavioral: SMS-messages
38 Recruiting Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: entecavir;   Drug: Thymosin-α
39 Completed Enteral Nutrition in Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Dietary Supplement: High Protein Energy, Fresenius-Kabi (nutritional intervention)
40 Recruiting Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Other: No relevant intervention.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.